RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 108 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $126,000 | -46.6% | 22,802 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $236,000 | -47.4% | 24,408 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $449,000 | -27.2% | 25,138 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $617,000 | +11.4% | 25,263 | +20.9% | 0.00% | 0.0% |
| Q1 2021 | $554,000 | +250.6% | 20,889 | +0.3% | 0.00% | +100.0% |
| Q4 2020 | $158,000 | +47.7% | 20,834 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $107,000 | -18.3% | 21,433 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $131,000 | +42.4% | 21,919 | +6.0% | 0.00% | 0.0% |
| Q1 2020 | $92,000 | -55.8% | 20,684 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $208,000 | +20.2% | 21,880 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $173,000 | -50.4% | 22,065 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $349,000 | -11.2% | 22,218 | +2.2% | 0.00% | 0.0% |
| Q1 2019 | $393,000 | +204.7% | 21,736 | +171.3% | 0.00% | 0.0% |
| Q4 2018 | $129,000 | -33.5% | 8,011 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $194,000 | – | 8,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |